FOXD1 and breast carcinoma: In basal-like breast cancer, FOXD1 could regulate enhancer gene programs associated with tumor progression and inhibition of FOXD1 could reduce metastasis by inactivating EMT-associated enhancers (Kumegawa et al., 2023).